FLEX vs IONS · P/E 23, rev $6.40B vs rev $226.6M
Flex Ltd (FLEX) versus Ionis Pharmaceuticals Inc (IONS) — a side-by-side from cached financials, not a winner call.
Flex Ltd (FLEX) is a electronic components company listed on US.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
Latest reported FLEX revenue for 2025-03-31 was $6.40B. Net income was $838.0M. Revenue was down 2.4% from 2024-12-31 to 2025-03-31. FLEX currently screens at market cap $18.12B and trailing P/E 23.0.
Latest reported IONS revenue for 2024-12-31 was $226.6M. Net income was -$104.3M. Revenue was down 30.2% from 2023-12-31 to 2024-12-31. IONS currently screens at market cap $12.28B.
FLEX currently screens at market cap $18.12B and trailing P/E 23.0. IONS currently screens at market cap $12.28B.
Not investment advice. Open the FLEX and IONS stock pages for the full models.
Not investment advice.